ePrints

Dysregulation of Neurotrophic and Haematopoietic Growth Factors in Alzheimer's Disease: From Pathophysiology to Novel Treatment Strategies

Lookup NU author(s): Professor Konstantinos StellosORCiD

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Abstract

Alzheimer's disease (AD) is the leading cause of dementia in the elderly. Growth factors have been demonstrated to act in a synergistic way in angiogenesis and neurogenesis contributing to self-healing powers of the adult human brain. A growing body of evidence demonstrates that levels of many growth factors (neurotrophins and hematopoietins) are altered in cerebrospinal fluid and peripheral blood from AD patients and in animal models of AD. The present review summarizes the role of several neurotrophic growth factors (e.g., BDNF, SCF, NGF, GDNF) and haematopoietic growth factors (e.g., G-CSF, VEGF, SDF-1) in AD. Moreover, we summarize recent studies evaluating the diagnostic and prognostic value of growth factor levels in blood and cerebrospinal fluid in patients with AD and discuss the potential role of these growth factors as a promising new therapeutic approach in AD. © 2014 Bentham Science Publishers.

Publication metadata

Author(s): Sopova K, Gatsiou K, Stellos K, Laske C

Publication type: Article

Publication status: Published

Journal: Current Alzheimer Research

Year: 2014

Volume: 11

Issue: 1

Pages: 27-39

Print publication date: 01/01/2014

Acceptance date: 01/01/2014

ISSN (print): 1567-2050

ISSN (electronic): 1875-5828

Publisher: Bentham Science

URL: https://doi.org/10.2174/1567205010666131120100743

DOI: 10.2174/1567205010666131120100743

PubMed id: 24251394

Altmetrics

Share